Benzinga's Top Downgrades
February 24, 2015 at 09:10 AM EST
Analysts at UBS downgraded Salix Pharmaceuticals Ltd. (NASDAQ: SLXP) from Buy to Neutral. The price target for Salix Pharmaceuticals has ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.